Limited Access Protocol of Posaconazole in Invasive Fungal Infections Study PO2095

NCT00177749 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Stopped Study is complete Analysis is complete

Conditions

Fungal Infection

Interventions

DRUG: Posaconazole

Sponsor

University of Pittsburgh

Collaborators

[object Object]